SOAT1 and hematologic disorder: Aberrant activation of JAK-STAT signaling, often driven by genetic mutations (supplementary tables) that occur upstream or within core components of the pathway, plays a pivotal role in the pathogenesis of various hematologic malignancies, including myeloproliferative neoplasms, acute leukemias, and mature lymphoid neoplasms (160).